University of California, Los Angeles (UCLA), Health Sciences

UCLA web app will enlist public’s help in slowing the spread of COVID-19

Leticia Ortiz | 

Newswise — A team of UCLA researchers has launched Stop COVID-19 Together, a web-based app that will enable the public to help fight the spread of the coronavirus. 

Through the site, anybody can take a brief survey that covers basic demographics, whether they have symptoms and their possible exposure to COVID-19. The system aggregates users’ responses to help the UCLA team find ways to reduce the spread of the virus, and to try to protect the health system from being overloaded.  

“The key contributors to Stop COVID-19 Together are the members of the public who contribute data to the effort, which is designed to predict the spread of COVID-19 throughout the community and to assess the effectiveness of current measures in that community, including physical distancing,” said Dr. Vladimir Manuel, a clinician, medical director of urgent care at UCLA Health and one of the project’s leaders. “We are extremely grateful to everyone who is contributing.” 

The app was created by UCLA experts from a range of fields, including engineering, data science, clinical medicine, epidemiology and public health. The project is an initiative of the AI in Medicine program at the UCLA Department of Computational Medicine, which is part of UCLA Health.

“One of the most pressing challenges with the coronavirus pandemic is the lack of information,” said Eran Halperin, a UCLA professor of computational medicine, computer science, human genetics and anesthesiology, and another leader of the project. “We do not have a clear understanding of how many people are infected, where they are or how effective the measures that we are taking to slow the spread have been. And we don’t know how much strain the virus will put on our local hospitals in the near and more distant future.” 

The system will build a map of possible hotspots where there may be a higher risk for accelerated spread of the disease. Identifying hotspots will be critical for helping hospitals and medical centers reduce the risk of becoming overloaded as the number of people with COVID-19 increases. The system will also inform the public where hotspots are located, and it is using artificial intelligence to predict where and when the disease will spread. That information could be useful to public officials — letting them know, for example, how effective physical distancing is in slowing the spread. 

“Our system will use machine learning tools to answer these questions and make predictions that will help us as a society be more prepared to fight this disease,” said Jeff Chiang, a data scientist on the team. 

Follow #TeamLA and #stopcovid19together on social media.




Filters close

Showing results

110 of 5584
Released: 7-May-2021 1:40 PM EDT
There is no evidence that vaccines could cause harm to people who have recovered from COVID-19
Newswise

An article published by Robert F. Kennedy Jr.’s anti-vaccination organization and widely shared on social media questions the need of vaccinating those who’ve already recovered from COVID-19. The article says there’s a "potential risk of harm, including death" in getting the vaccines. We report this claim as false. There is no evidence that vaccinating people who had previously had COVID is resulting in an increased risk of adverse events.

Newswise: Abbott.jpg
Released: 7-May-2021 1:00 PM EDT
FSU expert available to discuss intellectual property and COVID-19 vaccines
Florida State University

By: Bill Wellock | Published: May 7, 2021 | 11:55 am | SHARE: President Joe Biden has expressed his support for a World Trade Organization proposal to waive intellectual property rights for COVID-19 vaccines.Florida State University law professor Frederick Abbott, the Edward Ball Eminent Scholar Professor of International Law, is available to comment on international intellectual property rights and global economic issues around the proposal.

access_time Embargo lifts in 2 days
Embargo will expire: 11-May-2021 11:00 AM EDT Released to reporters: 7-May-2021 1:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-May-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 7-May-2021 11:15 AM EDT
Asthma attacks plummeted among Black and hispanic/latinx individuals during the COVID-19 pandemic
Brigham and Women’s Hospital

Asthma attacks account for almost 50 percent of the cost of asthma care which totals $80 billion each year in the United States

access_time Embargo lifts in 2 days
Embargo will expire: 11-May-2021 11:00 AM EDT Released to reporters: 7-May-2021 10:40 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-May-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 7-May-2021 9:00 AM EDT
Navigating the COVID-19 crisis to prevent pressure injuries: Learning health system helped one hospital adapt and update care in real time
Wolters Kluwer Health: Lippincott

Early in the COVID-19 pandemic, healthcare systems scrambled to modify patient care processes – particularly when it came to strategies aimed at reducing the risk of hospital-related complications. A look at how one hospital applied its learning health system (LHS) framework to respond to a COVID-19-related increase in hospital-acquired pressure injuries (HAPIs) is presented in the May/June Journal for Healthcare Quality (JHQ), the peer-reviewed journal of the National Association for Healthcare Quality (NAHQ). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: Ultra-Fast COVID-19 Sensor Invented at Texas Tech Gets Boost Into International Markets
Released: 7-May-2021 8:55 AM EDT
Ultra-Fast COVID-19 Sensor Invented at Texas Tech Gets Boost Into International Markets
Texas Tech University

EviroTech LLC announced today (May 7) a $4 million investment into the company by 1701 Ventures GmbH of Göttingen, Germany, which will allow EviroTech to complete the final design, production startup and market introduction of its Ultra-Fast COVID-19 detection sensor.

Released: 7-May-2021 7:05 AM EDT
Rutgers Recruiting Participants for Pfizer COVID-19 Pediatric Vaccine Clinical Trial
Rutgers University-New Brunswick

Rutgers has been selected as a clinical trial site for the global Pfizer-BioNTech research study to evaluate the efficacy of its COVID-19 vaccine in children ages 6 months to 11 years. This is the third time Rutgers has served as a COVID-19 vaccine clinical trial site for pharmaceutical companies. Last fall, it conducted trials for Moderna and Johnson & Johnson.


Showing results

110 of 5584

close
1.73337